Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06393621
Status:
COMPLETED
Last Update Posted:
2024-05-01
First Post:
2024-03-20
Brief Title:
Investigate the Effectiveness of KEFPEP on Regulating High Blood Pressure
Sponsor:
National Chung Hsing University
Organization:
National Chung Hsing University
Study Overview
Official Title:
Prospective Double-Blind Randomized Placebo-Controlled Parallel-Group Proof-of-Concept Study to Investigate the Effectiveness of KEFPEP on Regulating High Blood Pressure
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess the ability of KEFPEP to reduce blood pressure
Detailed Description:
Primary objective-
To assess the ability of KEFPEP to reduce blood pressure
Secondary objective-
1 To access the effect of KEFPEP on vascular inflammation or damage
2 To access the effect of KEFPEP on cardiovascular diseases prevention
3 To assess the safety of KEFPEP
To assess the ability of KEFPEP to reduce blood pressure
Secondary objective-
1 To access the effect of KEFPEP on vascular inflammation or damage
2 To access the effect of KEFPEP on cardiovascular diseases prevention
3 To assess the safety of KEFPEP
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 201707074MIPC | OTHER | NTUH-REC | None |